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Abstract
The beneﬁts of vaccination are clearly demonstrated by the eradication or enormous decline in the incidence of many vaccine-preventable
diseases, but the coverage of many highly recommended vaccines is still frequently inadequate and children continue to suffer from diseases
that could have been prevented. The main aim of this paper is to discuss the recognized barriers to the vaccination of children and
adolescents confronting national health systems, providers and parents, and the ways in which they can be overcome. Most of the problems
underlying limited vaccination coverage among children are due to a lack of understanding on the part of healthcare providers and parents,
which underlines the need for educational programmes speciﬁcally addressed to each of these groups. It is also essential that all of the
physicians providing immunization develop approaches that acknowledge parents’ concerns and respectfully try to correct any
misinformation. Other means of extending vaccine coverage include the implementation of adequate systems for recording vaccine
administration and the activation of effective reminder/recall systems, the provision of immunization services in some medical care
specialties or by integrating healthcare sites, and the elimination or reduction of all the problems that currently limit access to vaccination
services. However, it will take the combined efforts of healthcare systems and providers to pull down all of the barriers.
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Introduction
The beneﬁts of vaccination are clearly demonstrated by the
eradication or enormous decline in the incidence of many
vaccine-preventable diseases, but the coverage of many highly
recommended vaccines is still frequently inadequate and
children continue to suffer from diseases that could have
been prevented. The problem is paradoxically signiﬁcantly
more evident in children at risk of infectious disease-related
complications, but can also be found in otherwise healthy
children, at least in the case of some vaccines [1], such as
measles vaccine in Europe and pertussis vaccine in the USA. It
has been clearly shown that <95% of children in most
European countries receive the two recommended doses of
measles vaccine [2], and this is signiﬁcantly lower than the
minimum coverage required to eliminate the circulation of the
virus and disease development in susceptible subjects [3]. This
partly explains the recurrent reports of measles outbreaks
involving an increasing number of children and adolescents.
The most recent survey found that a total of 8499 measles
cases were diagnosed in Europe between March 2012 and
February 2013, with the highest incidence in Romania (4087
cases), the UK (2314), France (679) and Italy (592) [4]. It has
also been reported that the incidence of pertussis is increasing
in the USA, and that a number of epidemics have occurred in
various states [5]. Although this may be a result of factors such
as genetic changes in Bordetella pertussis, the decreased potency
of acellular vaccines, the greater awareness of pertussis and
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/1469-0691.12447
improvements in diagnostic tests, it is believed that many cases
are caused by waning immunity or inadequate immunization. In
2011, only 80.3% of children had received the recommended
four doses of diphtheria, tetanus and acellular pertussis vaccine
before the age of 24 months, and coverage among adolescents
was estimated to be only about 70% [6].
A number of studies have investigated the barriers to
immunization in children and adolescents in an attempt to
understand why some vaccine-preventable diseases are still
relatively common, even in countries with modern and highly
efﬁcient national health systems. The main aim of this paper is
to discuss the recognized barriers to the vaccination of
children and adolescents confronting national health systems,
providers and parents, and the ways in which they can be
overcome.
Health System Barriers
Table 1 summarizes the logistic barriers that can inﬂuence
vaccine administration. Where vaccines are not given free of
charge, cost remains a substantial barrier to immunization [7],
and vaccines with stringent storage requirements such as
varicella vaccine may present a challenge [8].
However, some of the most obvious barriers are factors
affecting the supply and distribution of vaccines. Vaccine
shortages due to a lack of manufacturing capacity are relatively
common, and there have been a number of recent reports
concerning late or inadequate supplies of inﬂuenza, tetanus,
heptavalent pneumococcal conjugate (PCV7) and measles/
mumps/rubella (MMR) vaccines, particularly in the USA [9]. In
an attempt to reduce the negative impact of shortages,
temporary changes in the administration guidelines are usually
suggested. However, these are not always sufﬁcient and a
signiﬁcantly higher than expected number of children at high
risk of infection do not receive adequate immunization.
Between December 2007 and September 2009, there was a
shortage of Haemophilus inﬂuenzae type b (Hib) vaccine in the
USA because of a lack of manufacturing capacity at one of the
companies producing the vaccine. To ensure that all children
received at least the primary series and to minimize the
possibility of children having no Hib immunity, and bearing in
mind that other companies could regularly produce the
vaccine, it was recommended to suspend the administration
of the booster dose to most children temporarily without
varying the administration of the recommended primary series
during the ﬁrst year of life. However, data from the 2009
National Immunization Survey revealed that not only was the
percentage of children fully vaccinated with the primary series
plus booster greatly reduced nationally, but also the percent-
age of children who had received the Hib primary series by the
age of 9 months of age was also reduced by c.7%, with
signiﬁcant variations among states [10]. The possible reasons
for this include local mismatches in vaccine supply and demand,
and the challenges felt by healthcare providers to order the
available combined or monovalent Hib products and incorpo-
rate them into ofﬁce practice. It was also suggested that
providers who were familiar with ordering the vaccine from
one manufacturer may have experienced difﬁculties in ordering
it from a different manufacturer [10]. This highlights the need
for better communications at national, state and local levels to
ensure that interim changes in vaccine recommendations are
implemented efﬁciently and effectively. The administration of
vaccine may be delayed during times of shortages at the time of
a child’s visit, but appropriate reminder/recall (RR) systems
should be prepared to ensure that all children receive the right
number of vaccine doses when the vaccine is once again
available.
A lack of adequate information from vaccine providers
regarding the vaccination status of each child to whom they
should administer the recommended vaccines can signiﬁcantly
inﬂuence vaccination coverage, and it has been shown that the
use of computerized, population-based systems that collect
and consolidate vaccination data is essential to this end [11].
These systems not only support clinical decision making and
provide vaccination coverage reports, but they can also help in
vaccine inventory management and have the ability to generate
RR messages. Unfortunately, such systems are not fully
developed or really effective in many countries and, in some
cases, providers themselves negatively interfere with their use.
Although the USA has had an immunization information
system since 1997, only 82% of the children aged <6 years who
had received at least one vaccination were entered in it in
2010 [12].
The availability of an RR system does not ensure a signiﬁcant
increase in vaccination coverage if the system is not adequately
TABLE 1. Main health system barriers to immunization and
possible solutions
Health system barrier Solution
Cost Fair reimbursement or administration free of
charge
Difﬁcult vaccine storage Improve quality management system
Reduced vaccine supply
and distribution
Implementation of efﬁcient and effective
recommendations to minimize the problem;
improve vaccine infrastructure
Lack of a system to collect
and consolidate vaccination
status of single individuals
Computerized immunization registries; activation
of reminder/recall systems; establishment of a
platform for adolescent immunization with an
age-based recommendation; vaccination
requirements for child care, school and college
attendance
Missed opportunities Integration of healthcare sites; information
through schools
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implemented. A recent systematic review of studies that have
evaluated the problems related to the use of immunization RR
systems has shown that many perceived barriers must still be
overcome before their full beneﬁts can be reaped [13]. The
most frequently described were the human and ﬁnancial
resources associated with implementing an RR system, and a
lack of conﬁdence in the accuracy of patient immunization
records due to inadequate communication among multiple
immunization providers. Other barriers were changes in staff
workﬂows, the absence of appropriate electronic
patient-tracking facilities and uncertainties concerning the
success of such a system. Finally, it was noted that the
effectiveness of an RR system designed to improve vaccination
in at-risk children can vary depending on the intimacy between
the healthcare workers managing the system and the patients
or their families. Esposito et al. [14] studied whether a
telephone RR system directly managed by the paediatricians
who usually followed up asthmatic children and were well
known to the family was more effective than an anonymous RR
system, and found that vaccination coverage was 61% when
the mothers were contacted and the vaccine was administered
by known paediatricians, but signiﬁcantly lower (p <0.01)
when unknown healthcare workers were involved. The results
were slightly different when the same authors carried out a
similar study involving children with oncohaematological
malignancies [15]: there was no difference in the effectiveness
of the various RR systems in terms of inﬂuenza vaccination
coverage, although the best results were obtained in children
who had completed chemotherapy fewer than 6 months
before. This seems to suggest that the parents’ perception of
the importance of the underlying disease and its treatment in
conditioning the risk of infection can also affect the effective-
ness of an RR system. All of these ﬁndings underline the need
for the appropriate preparation of vaccination archives and
adequate instructions of providers to parents.
Missed opportunities (MOs) for administering vaccines or
recalling the need for their administration are other barriers to
fulﬁlling immunization requirements in a timely fashion. Turner
et al. [16] studied the medical records of about ten randomly
selected children aged <2 years from each of 62 primary-care
practices in Auckland, New Zealand. The 616 audited children
made 10 094 visits to their general practitioners: MOs
occurred at 60 practices (97%) during 556 visits (5.5%), and
involved 31% of the children. Overall, the children with a
recorded MO were 3.1 times more likely to be incompletely
immunized than those with no recorded MO (95% CI 1.87–
5.14), and this likelihood increased to up to nine times in the
case of the children with a higher percentage of visits that
represented MOs. Nurse visits were less affected by MOs than
doctor visits (1.5% vs 6%) but were more likely when they
involved children who were well [16]. Similar data were
collected by Schaffer et al. [17] and Smith et al. [18], who
found that the risk of MOs to check vaccination status or
administer vaccines was greater during visits involving sick
children.
The importance of reducing MOs seems to be particularly
important in the case of adolescents throughout the world
[19,20]. Adolescents are frequently no longer followed by
paediatricians and, when they need medical care, contact
specialists who are not interested in the question of immu-
nization; moreover, they can easily escape parental control.
Consequently, many of them do not receive the vaccines that
are particularly important, such as those against sexually
transmitted diseases. To overcome the problem in the USA, it
has been suggested that medical homes (i.e. healthcare settings
that offer continuous, comprehensive and accessible primary
care) are optimally suited to provide adolescent immunization
[19] but, where such facilities are not available, the integration
of healthcare sites by means of automatic reports of immu-
nizations received in complementary settings is essential.
Schools can also be used to increase adolescent immunization
by introducing speciﬁc educational programmes concerning
the importance of vaccines, verifying adolescent immunization
records and strongly encouraging the students to undergo
needed vaccinations [20]. In the developing world, it has been
shown that integrating additional child survival interventions
(i.e. antibiotic administration, nutritional supplementations,
insecticide-treated bed nets) with immunization programmes
is very effective [21]. A UNICEF study carried out in targeted
districts in four West African countries showed that this type
of integration reduced mortality in the under-5s by 20% as
result of the use of routine preventive services, increased
immunization, vitamin A supplementation and insecti-
cide-treated bed nets [22].
Provider Barriers
In addition to the logistic barriers mentioned above, providers
can substantially reduce immunization because of a lack of
knowledge of its indications and contraindications (Table 2).
TABLE 2. Main provider barriers to immunization and pos-
sible solutions
Provider barrier Solution
Poor knowledge of immunization indications
and contraindications
Educational programmes
Poor access to children’s immunization records Immunization registries
Missed visits, missed opportunities Use of reminder/recall systems
Poor communications with parents and
adolescents
Educational programmes
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This is a long-standing problem, but it has become even more
important now that the number of vaccines recommended for
healthy children and at-risk categories of patients has signif-
icantly increased. Providers may ﬁnd it difﬁcult to keep abreast
of current immunization schedules and guidelines, particularly
when the use of some vaccines is not universally recom-
mended and there is debate concerning their administration to
healthy subjects [23].
This is the case for inﬂuenza vaccine which, in most
European countries, is not recommended for healthy children
and has only recently been recommended for pregnant
women. A cross-sectional study of obstetricians/gynaecolo-
gists, neonatologists and paediatricians carried out in Italy
(where inﬂuenza vaccine is recommended only in high-risk
subjects of any age, pregnant women and the elderly) clearly
showed that only about 50% of these providers considered
inﬂuenza a potentially serious disease for younger children and
pregnant women, and that they knew very little about the
characteristics of inﬂuenza vaccines and the recommendations
for their use [23]. This was underlined by the fact that very few
of the interviewed healthcare workers underwent vaccination
themselves, and most of those who did said that they did so to
protect their families rather than their patients.
However, studies have shown that paediatricians are more
likely to administer vaccines according to ofﬁcial recommen-
dations than are general practitioners. Zimmerman et al. [24]
explored physicians’ knowledge of varicella vaccine and found
that paediatricians were likely to administer varicella vaccine to
more than 90% of children regardless of their age, whereas
GPs complied with the ofﬁcial guidelines in about 70% of the
cases (p <0.01), mainly older children.
Providers generally know the least about the use of
vaccines. One study of providers and clinical staff in California
compared their immunization-relevant knowledge, certainty
about knowledge, self-efﬁcacy, vested interests and reported
practices, and found that, although physicians were signiﬁcantly
more knowledgeable than providers (p <0.001), they were not
more certain about their knowledge (p 0.52), nor were they
more conﬁdent about properly immunizing all of the children
in their practices (p 0.10) [25]. Providers also reported a
lower vested interest in immunizations than clinical staff
(p <0.05), and were less likely to defer needed immunizations
for a 15-month-old child (p <0.05), more likely to administer
multiple injections to an 18-month-old child (p <0.05), and
more likely to immunize during visits concerning acute and
chronic illnesses. These discrepancies in reported immuniza-
tion practices between providers and staff may be a barrier to
full immunization [25].
One group of healthcare workers that is sometimes
reported as having a negative attitude towards immunization
are the providers of complementary medicine [26–28]. Lehrke
et al. [29] questioned medically qualiﬁed homeopathic practi-
tioners and non-homeopathic physicians (including some
paediatricians) about the recommendations and administration
of 17 vaccines, and found that the homeopathic physicians did
not generally refuse all of the vaccines but viewed them as
having a speciﬁc hierarchy: they administered classic vaccines
such as tetanus, diphtheria and polio vaccines to almost the
same extent as their non-homeopathic colleagues, but con-
sidered vaccines against other diseases ineffective and poorly
accepted.
Inadequate knowledge of the advantages of vaccinations
among healthcare workers can have substantial negative effects
on vaccination coverage. Primary-care providers play a central
role in educating patients and parents on the safety and
effectiveness of the vaccines recommended by health author-
ities, and can positively inﬂuence the rates of immunization just
by answering parents’ questions and addressing common
misconceptions. A number of studies have clearly shown that
parents consider healthcare workers to be the most important
source of information when deciding whether their child
should be given a vaccine [30,31]: it is well known that
dissatisfaction with the information given by doctors is one of
the most frequently reported reasons for low vaccine
acceptance rates [32], whereas physician recommendation is
one of the strongest predictors of immunization. Esposito
et al. [33] found that the main reason leading the parents of
high-risk children to have them vaccinated against inﬂuenza
was their physician’s strong recommendation. However, trust
in healthcare workers can be compromised by perceived
conﬂicting interests, such as the knowledge that doctors may
be ﬁnancially rewarded for achieving high vaccine coverage
rates [34,35]. The attitude of providers when describing the
characteristics of a vaccine can also lead to different parental
decisions: if they are too resolute about the importance of
vaccines, parents may question their motives whereas, if they
sound vague, parents may interpret this as indicating that the
vaccine has a problem.
As healthcare workers’ knowledge of vaccines is one of the
most critical points conditioning vaccine acceptance by
parents, it is essential to implement educational programmes
to improve their knowledge or change their attitudes,
particularly when new vaccines are introduced or the guide-
lines are modiﬁed. Although not based on very intensive
interventions, studies have shown that educational pro-
grammes seem to be effective [36]. However, it is difﬁcult to
evaluate their importance in increasing vaccination coverage
precisely because provider education is just one of several
effective multi-component interventions that also include
provider reminders, assessments and feedback.
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Parental Barriers
Table 3 summarizes parental barriers to vaccination and
possible means of overcoming them. Although there are
differences among countries, ethnic groups and socioeconomic
groups, a number of studies have shown that parents per se can
obstruct the immunization of their children. Confusing vacci-
nation schedules, costs, religious objections, frequent child-
hood illnesses leading to delayed immunization, difﬁculties in
remembering an appointment and transportation problems are
frequent reasons given by parents to explain why their children
were not vaccinated at the appropriate time or not at all [37].
However, most of the negative parental attitudes are due to
a lack of knowledge of the clinical relevance of many
vaccine-preventable diseases and the very good safety and
tolerability of all of today’s marketed vaccines. A number of
vaccine-preventable diseases are now very rare and memory
of them has weakened. As a result, their effects are minimized
and their prevention is considered unnecessary. The same
occurs when the disease against which a vaccine has been
prepared is considered not to be serious because other
children have suffered from it without any signiﬁcant clinical
problems or when a vaccine is presumed to be effective against
a disease that may develop years later, as in the case of human
papillomavirus (HPV) vaccine. An Italian study of adolescents
and parents found that only 68% of mothers and 65% of fathers
were in favour of vaccinating their children against HPV, that
only 45% of the female adolescents were aware that HPV
infection could concern themselves, and only 68% would
undergo vaccination [38].
Some parents believe that the immunity evoked by vaccines
is less effective than that due to natural disease, and they
prefer to face the risks of illness rather than those of
immunization. This was clearly shown by Prislin et al. [39], who
found that, together with safety concerns, beliefs in natural
immunity were the main contributors to parents’ negative
attitudes to vaccinations. Another common misconception is
that the administration of too many immunizations weakens
the immune system or causes chronic diseases such as asthma,
diabetes or multiple sclerosis. In a US survey, Gellin et al. [40]
found that 25% of parents believed that their child’s immune
system could become weakened as a result of too many
immunizations, and 23% believed that children receive more
immunizations than is good for them.
Finally, vaccines are frequently considered unsafe because
the dissemination of misinformation and anecdotal reports of
alleged vaccine reactions by the media, the Internet and
anti-vaccination groups leads parents to question the need for
immunization. The best examples of this are the irresponsible
attributions of MMR vaccine as a cause of autism [41] and
hepatitis B vaccines as a cause of chronic fatigue syndrome or
multiple sclerosis [42]. A study carried out in the UK found
that MMR and meningococcal C were the most frequently
omitted of the recommended vaccines, usually because of
concerns about vaccine safety [43]. About one-third of the
interviewed parents perceived that having their child immu-
nized was more risky than non-immunization, particularly in
the case of MMR and meningococcal C vaccines. Those who
agreed to be interviewed were notably concerned about the
MMR vaccine, but not about immunization in general [43].
As paediatricians are the primary source of immunization
information for most parents and adolescents, they can
effectively remove most of the barriers and increase vaccina-
tion coverage. Providers should explain all of the beneﬁts and
risks of vaccines in detail, acknowledging parental concerns and
respectfully trying to correct any misconceptions. People
perceive risks differently, and so the way in which possible
risks are communicated is critical. Although paediatricians may
focus on the statistics concerning the general effectiveness of
vaccines and the known risks of vaccine-preventable diseases,
parents making vaccination decisions may perceive risks in a
broader religious, cultural and personal context [44].
Parents who refuse vaccinations and rely on herd immunity
should be informed that this is not only negative for their child,
but also for the community. The study by Feikin et al. [45]
could be cited in this case, because they found that the
frequency of exemptors in a county was associated with the
incidence of measles (relative risk (RR) 1.6; 95% CI 1.0–2.4)
and pertussis (RR 1.9; 95% CI 1.7–2.1) in vaccinated children.
The schools with pertussis outbreaks had more exemptors
(mean 4.3%) than schools without (mean 1.5%; p 0.001), and at
least 11% of vaccinated children in measles outbreaks acquired
the infection as a result of contact with an exemptor.
If a parent or adolescent continues to refuse vaccination,
this should be documented in the medical records. Some
experts suggest that parents should sign a document acknowl-
edging that the vaccination was refused. Moreover, a ﬁnal
attempt to convince parents could be made as suggested by
TABLE 3. Main parental barriers to immunization and pos-
sible solutions
Parental barrier Solution
Poor understanding of the real value of
vaccines
Educational programmes; adequate
information from physicians
Fear of adverse events Educational programmes; adequate
information from physicians
Problems in understanding the complex
vaccination schedule
Educational programmes; adequate
information by physicians
Logistic problems to reach clinics Economic help
Economic problems Vaccines free of charge
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Baron [46], who found that people opposed to vaccination
could be persuaded to vaccinate if they placed themselves in
the child’s position and then asked themselves whether they
preferred a greater or lesser chance of death, and whether it
mattered if the outcome occurred as a result of someone’s act
or omission.
Conclusions
As most of the problems that lead to low vaccination coverage
in children depend on the lack of knowledge of vaccines of
healthcare providers and parents, educational programmes
should be speciﬁcally aimed at each of these groups. Moreover,
the design and development of new vaccines and the
alternative routes of administration should represent a pos-
sible solution for overcoming barriers to immunization. It is
also essential that all physicians providing immunization
develop approaches that acknowledge parental concerns and
respectfully try to correct any misconceptions. The risk of
non-acceptance can be further reduced by implementing
systems for recording vaccine administration and sending out
reminders, providing immunization services in special medical
homes or by integrating healthcare sites. Finally, so-called ‘civil
society organizations’ (CSOs) [47] could play an important
role in the introduction and sustainability of new vaccination
programmes, as has been seen in the recent introduction of
HPV vaccination in Europe, when the patients’ and women’s
groups that were traditionally advocates of treatments also
became advocates for prevention. CSOs can also be active at
national level by supporting national policy-makers, and can
bring innovative and effective new approaches to communi-
cating the beneﬁts of vaccination by means of public events,
celebrity messages and social media blogs. Working with
experts, CSOs can be an important bridge between the
scientiﬁc community and the lay public, which could provide a
vital counterbalance to media hype and anti-vaccination groups
—although it must also be remembered that they can be active
and vocal opponents of immunization.
Although various possibilities of improving vaccination
coverage have been identiﬁed, achieving the levels necessary
to obtain the greatest effect is still a difﬁcult goal that will only
be reached by the combined efforts of healthcare systems and
providers.
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